HERTFORDSHIRE, England, and
PITTSBURGH, Feb. 8, 2018 /PRNewswire/ -- Mylan N.V.
(NASDAQ, TASE: MYL) today announced that it will release its fourth
quarter and full year 2017 financial results, as well as its 2018
financial guidance, on Wednesday, Feb.
28, following the close of the U.S. financial markets.
The company will also host a webcast at 5:00
p.m. ET on Feb. 28, to discuss
the results and 2018 guidance.
The briefing can be accessed live by calling 800.514.4861
or 678.809.2405 for international callers (ID#: 4095484)
or at the following address on the company's website:
investor.mylan.com. A replay of the webcast also will be
available on the website.
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of more than 7,500 marketed products around the world,
including antiretroviral therapies on which more than 40% of people
being treated for HIV/AIDS globally depend. We market our products
in more than 165 countries and territories. We are one of the
world's largest producers of active pharmaceutical ingredients.
Every member of our approximately 35,000-strong workforce is
dedicated to creating better health for a better world, one person
at a time. Learn more at Mylan.com. We routinely post information
that may be important to investors on our website at
investor.mylan.com.
View original content with
multimedia:http://www.prnewswire.com/news-releases/mylan-to-release-2017-fourth-quarter-and-full-year-results-and-2018-guidance-on-feb-28-2018-300595917.html
SOURCE Mylan N.V.